About Smartcella
SmartCella is a global biotech company pioneering the future of targeted therapies through delivery solutions and advanced therapy development. Founded in 2014, the company is built on globally renowned science and research from Karolinska Institutet in Sweden.
SmartCella combines novel delivery platforms, such as the Extroducer®, an endovascular delivery device that enables direct injection to hard-to-reach organs and tissues, with state-of-the-art development and manufacturing of cell therapies. The company operates in two business segments: Targeted Delivery and Regenerative Medicines.
SmartCella is privately owned and funded
Founded in 2014 and headquartered in Stockholm, Sweden
